• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AXONICS, INC. BULKAMID INJECTABLE IMPLANT; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AXONICS, INC. BULKAMID INJECTABLE IMPLANT; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE Back to Search Results
Lot Number 22F1602
Patient Problems Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Rash (2033)
Event Date 11/03/2023
Event Type  Injury  
Event Description
On (b)(6) 2023, i had urethral bulkamid injections.By evening of (b)(6) 2023, i was itching and was starting to break out in a rash.The rash continued to spread across my body through out the following days.I have had multiple doctors' visits, lab tests, and medications, including at least four courses of prednisone.I still have rash.Even though i have finished my fourth course of prednisone, this time for 6 weeks.I am in my fourth month of having a rash (very itchy).I think i am experiencing a reaction to having this bulkamid gel inside me.Multiple lab tests have been run to eliminate or find what is the cause of this ongoing rash; including punch biopsy of rash site.No other existing health conditions have been found.Ref reports: mw5152649, mw5152651, mw5152652.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BULKAMID INJECTABLE IMPLANT
Type of Device
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Manufacturer (Section D)
AXONICS, INC.
MDR Report Key18886547
MDR Text Key337596235
Report NumberMW5152650
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 02/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot Number22F1602
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/11/2024
Patient Sequence Number1
Treatment
ACETAMINOPHEN ; CETIRIZONE; FAMOTIDINE; FEXOFENADINE; GLIMEPIRIDE; HYDROXYZINE; KENALOG ; SINGULAIR; TERAZOSIN
Patient Outcome(s) Other;
Patient Age71 YR
Patient SexFemale
Patient Weight95 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-